Thermo Fisher Scientific Reports Third Quarter 2025 Results

Thermo Fisher raises 2025 guidance to $44.5B revenue and $22.86 EPS as operational momentum strengthens (NYSE:TMO)

Get key insights from Thermo Fisher’s Q3 2025 earnings: robust growth, raised guidance, innovation, and strategic deals.

Thermo Fisher Scientific Reports Third Quarter 2025 Results

WALTHAM, Mass.--(BUSINESS WIRE)--Oct 22, 2025-

Thermo Fisher's Upbeat Earnings Suggest Worst Is Over For Scientific Tools Sector, Analyst Says

Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported third-quarter 2025 adjusted earnings of $5.79 per share, beating the street view of $5.49. • TMO stock is showing upward bias. Get the inside scoop here. Quarterly sales of $11.12 billion increased 5% year-over-year, beating the…

Thermo Fisher's Q3 results show strong demand for lab infrastructure amid pharma R&D Boom

Thermo Fisher Scientific beat Wall Street expectations in the third quarter of 2025, reporting $11.12 billion in revenue and adjusted earnings of $5.79 per share. The results signal resilience for lab infrastructure demand even as U.S. research budgets face headwinds and the U.S. government shutdown is in its 22nd day. The Waltham, Mass.–based company’s Laboratory… The post Thermo Fisher’s Q3 results underscore steady demand for lab infrastructu…